Results 241 to 250 of about 98,962 (385)

BIOPHARMACEUTICS AND PHARMACOKINETICS

, 2023
Dr. Chatlapelli Kishore, Mr. Pavan Kumar Krosuri, Prof. (Dr.) Ajit Kumar Acharya, Dr. L. Matsyagiri   +3 more
openaire   +1 more source

Nobiletin Ameliorates Aβ1–42‐Induced Cognitive Disorder and Mitochondrial Dysfunction via Targeting the Key Circadian Regulator Bmal1

Food Safety and Health, EarlyView.
Nobiletin (NOB) ameliorates Aβ‐induced Alzheimer’s pathology by restoring circadian rhythm via Bmal1. NOB rescues cognitive deficits, synaptic damage, and mitochondrial dysfunction in mice and neurons by enhancing Bmal1/Clock oscillations and downstream mitochondrial integrity, positioning circadian regulation as a therapeutic target for Alzheimer's ...
Huajing Gao, Qinglin Qu, Ning Wang, Xue Gao, Peihua Li, Yanquan Mou, Xiangrui Kong, Yannan Chen, Dapeng Li, Xintong Tan   +9 more
wiley   +1 more source

The Nonfeminizing Enantiomer of 17β-Estradiol Exerts Protective Effects in Neuronal Cultures and a Rat Model of Cerebral Ischemia**This work was supported by NIH Grants AG-10485 (to J.W.S.) and GM- 47969 (to D.F.C.), U.S. Army Grant DAMD-17–99-1–9473 (to J.W.S.), and Apollo Biopharmaceutics, Inc. funding (to J.W.S. and D.F.C.).

, 2001
Pattie S. Green, Shao-Hua Yang, Kent R. Nilsson, Aman Kumar, Douglas F. Covey, James W. Simpkins   +5 more
openalex   +1 more source

CultiFlask 50: a versatile tool for media optimization in biopharmaceutical production [PDF]

, 2007
Joachim Luecke
openalex   +1 more source

Correction: Association of lymphocyte subsets percentage with prognosis for recurrent or metastatic nasopharyngeal carcinoma patients receiving PD-L1 inhibitors. [PDF]

Cancer Immunol Immunother
Diao J, Wei Z, Pei Y, Ge J, Qing Y, Wei Y, Chen Y, Peng X.   +7 more
europepmc   +1 more source

Monitoring patients treated with anti-TNF- biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies [PDF]

, 2007
Morten Svenson, P. Geborek, Tore Saxne, Klaus Bendtzen   +3 more
openalex   +1 more source

Biopharmaceutics and Pharmacokinetics

, 2015
R. Thirumurugan, T.N.K. Suriyaprakash, S. Lakshmana Prabu, Kandasamy Ruckmani   +3 more
openaire   +3 more sources

Author Correction: Chlorin e6-associated photodynamic therapy enhances abscopal antitumor effects via inhibition of PD-1/PD-L1 immune checkpoint

Scientific Reports, 2023
Pallavi Gurung, Junmo Lim, Rajeev Shrestha, Yong‑Wan Kim   +3 more
doaj   +1 more source

Physiologically Based Pharmacokinetic Modeling of Efavirenz Nanoparticles: from Animal Model to Human Extrapolation. [PDF]

ACS Omega
da Silva TM, Sarcinelli MA, Cunha Chaves MH, Dias AA, Patricio BFC, Prado LD, Tasso L, Duque MD, Rocha HVA.   +8 more
europepmc   +1 more source

The European Clinical Trials Directive: What does this mean for the biopharmaceutical industry?

, 2001
Simon Bryson
openalex   +1 more source